Clinical Trial: A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase I, Double-Blind Single and Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of A4250 as Monotherapy, and in Combination With Colonic Release Cholestyramine (A3384) or Commer

Brief Summary: The primary objectives of the study are to evaluate the safety, tolerability and pharmacokinetics of A4250 after single or multiple oral doses in healthy subjects. In addition, will evaluate A4250 in combination with cholestyramine.